Brain peptide-containing composition for relieving anxiety and improving sleep as well as preparation method and application of brain peptide-containing composition

By combining the brain peptide composition containing components such as apple concentrate powder, brain peptide powder, casein peptide, jujube seed compound powder and γ-aminobutyric acid, the side effects and large doses of sleep products in the prior art are solved, and the problem of improving sleep products is achieved. Small doses and efficient anxiety relief and sleep improvement effects.

CN119054930AActive Publication Date: 2024-12-03HANGZHOU BIBAU BIOTECHNOLOGY CO LTD +1

Patent Information

Application Number
CN202411556620.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-11-04
Publication Date
2024-12-03
Estimated Expiration
2044-11-04

AI Technical Summary

Technical Problem

The products that improve sleep in the prior art have side effects or require high doses, and the effect needs to be further improved, making it difficult to effectively relieve anxiety and improve sleep.

Method used

By combining the components of apple concentrate powder, brain peptide powder, casein peptide, jujube seed compound powder and gamma-aminobutyric acid, a brain peptide containing composition is prepared for preparing functional foods to relieve anxiety and improve sleep. Add auxiliary materials such as citric acid, xanthan gum, etc. to improve taste and stability.

Benefits of technology

This composition has the characteristics of small doses and significant effects. It can significantly prolong sleep time, improve sleep incidence, and shorten sleep latency, which is significantly better than the control group and proportional compositions in the prior art.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The invention provides a brain peptide composition for relieving anxiety and improving sleep as well as a preparation method and application of the brain peptide composition, and relates to the technical field of functional foods. The brain peptide-containing composition is prepared from the following components: 1 to 5 parts of apple concentrated powder, 0.1 to 0.6 part of brain peptide powder, 1 to 5 parts of casein peptide, 0.5 to 1.5 parts of spina date seed composite powder, 0.1 to 0.5 part of gamma-aminobutyric acid, 0.5 to 1.5 parts of lemon concentrated powder, 0.5 to 3 parts of stachyose and 0.05 to 0.3 part of taurine. Through repeated compounding of the brain peptide powder, the casein peptide, the spina date seed composite powder and the gamma-aminobutyric acid, the obtained composition has the characteristics of small dosage and better effects of relieving anxiety and improving sleep.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of functional foods, and in particular relates to a brain peptide composition for alleviating anxiety and improving sleep, and a preparation method and application thereof. Background Art

[0002] With the development of modern society, the number of people suffering from insomnia is increasing. Long-term insomnia can lead to reduced immunity, induce gastrointestinal diseases, cardiovascular and cerebrovascular diseases, etc. At present, taking Western medicine is the main way to treat insomnia. Benzodiazepines, melatonin, etc. have side effects to varying degrees. Therefore, a product that can significantly help sleep and improve sleep without toxic side effects is needed.

[0003] For example, Chinese invention patent application CN116268400A discloses a health food for improving sleep, the formula composition is 6-10% American ginseng, 50-74% longan pulp, 14-22% magnolia officinalis flower, 10-14% cyperus rotundus. The formula has three experimental results, namely, positive results in the experiment of extending the sleeping time of sodium pentobarbital, the hypnotic experiment of sodium pentobarbital subthreshold dose and the sleep latency experiment of sodium pentobarbital, indicating that the health food of the present invention has the effect of improving sleep. However, in the application, Chinese herbal medicine raw material extracts are directly used as medicine, the oral dosage is large, and a large amount of flavoring agents need to be added to improve the acceptance of the test population.

[0004] For example, Chinese invention patent application CN118383525A discloses a sleep-improving compound and its application, wherein the raw materials of the sleep-improving compound are: 10-70 parts of bovine casein enzymatic hydrolyzed peptide powder, 10-70 parts of longan extract, 10-70 parts of Poria cocos extract, and 0.01-0.5 parts of γ-aminobutyric acid. The compound of the present invention is safer, has no dependence and adverse reactions, has a good sleep-improving effect, and the raw materials used in the compound are low in price, and has practical significance and application value for development as a health food, but its effect needs to be further improved.

[0005] Therefore, there is an urgent need to develop a composition with a small dosage and better effects of relieving anxiety and improving sleep. Summary of the invention

[0006] The present invention aims at the problems existing in the prior art and provides a brain peptide composition for relieving anxiety and improving sleep, as well as a preparation method and application thereof. Through multiple compounding of brain peptide powder, casein peptide, jujube seed composite powder and gamma-aminobutyric acid, the obtained composition has the characteristics of small dosage, better anxiety relief and sleep improvement effects.

[0007] One of the purposes of the present invention is to provide a brain peptide composition for relieving anxiety and improving sleep. The brain peptide composition comprises the following components by mass: 1-5 parts of apple concentrated powder, 0.1-0.6 parts of brain peptide powder, 1-5 parts of casein peptide, 0.5-1.5 parts of jujube seed composite powder, 0.1-0.5 parts of gamma-aminobutyric acid, 0.5-1.5 parts of lemon concentrated powder, 0.5-3 parts of stachyose and 0.05-0.3 parts of taurine.

[0008] Preferably, the brain peptide-containing composition comprises the following components in parts by mass: 1-3 parts of apple concentrated powder, 0.1-0.3 parts of brain peptide powder, 1-3 parts of casein peptide, 0.5-1 parts of jujube kernel composite powder, 0.1-0.3 parts of γ-aminobutyric acid, 0.5-1.2 parts of lemon concentrated powder, 0.5-2 parts of stachyose and 0.05-0.15 parts of taurine.

[0009] Preferably, the brain peptide-containing composition comprises the following components in parts by mass: 3 parts of apple concentrated powder, 0.2 parts of brain peptide powder, 2 parts of casein peptide, 0.8 parts of jujube kernel composite powder, 0.2 parts of γ-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 parts of taurine.

[0010] Preferably, the weight ratio of the Suanzaorensis seed composite powder to γ-aminobutyric acid is 3-8:1.

[0011] Preferably, the weight ratio of the brain peptide powder, casein peptide and γ-aminobutyric acid is 1-2:8-12:1-2.

[0012] Preferably, the brain peptide-containing composition further comprises a pharmaceutically acceptable excipient.

[0013] Further preferably, the auxiliary material is selected from at least one of citric acid, xanthan gum, sucralose, maltodextrin, soluble starch and lactose.

[0014] The second aspect of the present invention is to provide a method for preparing the above-mentioned brain peptide-containing composition, comprising the following steps: Mix apple concentrated powder, brain peptide powder, casein peptide, jujube seed composite powder, gamma-aminobutyric acid, lemon concentrated powder, stachyose and taurine, and add auxiliary materials to obtain the product.

[0015] The third aspect of the present invention is to provide the use of the above-mentioned brain peptide composition or the brain peptide composition prepared according to the above-mentioned preparation method in the preparation of functional foods for relieving anxiety and improving sleep.

[0016] Preferably, the functional food is a solid beverage, a compressed candy or an oral liquid.

[0017] Compared with the prior art, the present invention has the following beneficial effects: the composition obtained by the present invention has the characteristics of small dosage, better anxiety relief and sleep improvement effect through multiple compounding of brain peptide powder, casein peptide, jujube seed composite powder and gamma-aminobutyric acid. The effect of the composition of the present invention is significantly better than that of each comparative example and the blank control group. DETAILED DESCRIPTION

[0018] The following non-limiting examples can enable those skilled in the art to more fully understand the present invention, but do not limit the present invention in any way. The following content is merely an exemplary description of the scope of the present invention, and those skilled in the art can make various changes and modifications to the invention of the present invention based on the disclosed content, which should also fall within the scope of the present invention. In the embodiments of the present invention, the sources of the raw materials are as follows: Apple concentrate powder: Shandong Jiamei Food Industry Co., Ltd.; Brain peptide powder: Inner Mongolia Peptide Good Biological Products Co., Ltd.; Casein peptide: Guangdong Huapeptide Biotechnology Co., Ltd.; Ziziphus jujuba seed composite powder: Taizhou Pharmaceutical City Guoke Chemical Biopharmaceutical Technology Co., Ltd.; γ-aminobutyric acid: Bloomage Biotech Co., Ltd., 98%; Lemon concentrate powder: Fujian Green Spring Food Co., Ltd., BX: 58-62; Stachyose: Chengde Jingtian Food Technology Co., Ltd.; Taurine: Qianjiang Yongan Pharmaceutical Co., Ltd. Citric acid (anhydrous citric acid): Shandong Lemon Biochemical Co., Ltd.; Xanthan gum: Ordos Zhongxuan Biochemical Co., Ltd., 9270; Sucralose: Fujian Kehong Bioengineering Co., Ltd., KH-S100.

[0019] Embodiment 1: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 1 part of apple concentrated powder, 0.1 part of brain peptide powder, 1 part of casein peptide, 0.5 part of jujube seed composite powder, 0.1 part of gamma-aminobutyric acid, 0.5 part of lemon concentrated powder, 0.5 part of stachyose and 0.05 part of taurine.

[0020] Embodiment 2: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 5 parts of apple concentrated powder, 0.6 parts of brain peptide powder, 5 parts of casein peptide, 1.5 parts of jujube seed composite powder, 0.5 parts of gamma-aminobutyric acid, 1.5 parts of lemon concentrated powder, 3 parts of stachyose and 0.3 parts of taurine.

[0021] Embodiment 3: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 0.2 parts of brain peptide powder, 2 parts of casein peptide, 0.8 parts of jujube seed composite powder, 0.2 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0022] Comparative Example 1: A composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 2 parts of casein peptide, 0.8 parts of jujube seed composite powder, 0.4 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0023] The difference from Example 3 is that Comparative Example 1 does not contain brain peptide powder, and its amount is added to γ-aminobutyric acid, and the rest is the same as Example 3.

[0024] Comparative Example 2: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 0.4 parts of brain peptide powder, 2 parts of casein peptide, 0.8 parts of jujube seed composite powder, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0025] The only difference from Example 3 is that Comparative Example 2 does not contain γ-aminobutyric acid, and its amount is added to the brain peptide powder. The rest is the same as Example 3.

[0026] Comparative Example 3: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 0.2 parts of brain peptide powder, 2.8 parts of jujube seed composite powder, 0.2 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0027] The only difference from Example 3 is that Comparative Example 3 does not contain casein peptide, and its amount is added to the Suanzaorensis seed composite powder, and the rest is the same as Example 3.

[0028] Comparative Example 4: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 0.2 parts of brain peptide powder, 2.8 parts of casein peptide, 0.2 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0029] The only difference from Example 3 is that Comparative Example 4 does not contain the Ziziphus jujuba seed composite powder, and its amount is added to the casein peptide, and the rest is the same as Example 3.

[0030] Comparative Example 5: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 0.2 parts of brain peptide powder, 2 parts of casein peptide, 0.5 parts of jujube seed composite powder, 0.5 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0031] The difference from Example 3 is only in the amount of the jujube seed composite powder and the γ-aminobutyric acid and the weight ratio of the two. In Example 3, the amounts of the two are 0.8 parts and 0.2 parts respectively, and the weight ratio of the two is 4:1; while in Comparative Example 5, the amounts of the two are both 0.5 parts, and the weight ratio of the two is 1:1. Others are the same as in Example 3.

[0032] Comparative Example 6: A brain peptide composition for relieving anxiety and improving sleep comprises the following components by mass: 3 parts of apple concentrated powder, 0.6 parts of brain peptide powder, 1.2 parts of casein peptide, 0.8 parts of jujube seed composite powder, 0.6 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 part of taurine.

[0033] The difference from Example 3 is that the amount and weight ratio of brain peptide powder, casein peptide and γ-aminobutyric acid are different. In Example 3, 0.2 parts of brain peptide powder, 2 parts of casein peptide, 0.2 parts of γ-aminobutyric acid, and the ratio of the three is 1:10:1; while in Comparative Example 6, 0.6 parts of brain peptide powder, 1.2 parts of casein peptide, 0.6 parts of γ-aminobutyric acid, and the ratio of the three is 1:2:1. Others are the same as in Example 3.

[0034] Experimental Example 1 Effect on Sleep in Mice Healthy SPF Kunming female adult mice, weighing 18-22g. Purchased from the Experimental Animal Center of Shandong University, the experimental animal production license number is SCXK (Lu) -2020-0002. After 7 days of adaptive feeding, the experimental period began. After the adaptation period, 100 mice in good health were selected and divided into 10 groups according to the random number table method, with 10 mice in each group, namely, the blank control group, the Example 1-3 group, and the Comparative Example 1-6 group. The composition of the Example 1-3 group and the Comparative Example 1-6 group was diluted with deionized water and administered by gavage. The dosage was 500 mg of the composition / kg, and the administration volume was 2 mL / 100 g. The blank control group was gavaged with an equal dose of deionized water. After 30 days of continuous gavage, the following indicators for improving sleep were measured. At the same time, the weight of the mice was weighed and recorded on the 0th day of the experiment and the 30th day of the experiment.

[0035] 1.1 Direct sleep test The sleep phenomenon of the mice in Example 1-3 groups, Comparative Example 1-6 groups and the blank control group after the last gavage was observed; Judgment of sleep phenomenon: sleep is based on the disappearance of righting reflex as an indicator, that is, when the mouse is placed in a dorsal position, it can immediately turn over. If the mouse cannot turn over by itself within 60 seconds, it is considered that the righting reflex is lost and the mouse enters sleep; the time period from the disappearance of the righting reflex to the recovery is the sleep time of the mouse; the number of sleeping mice and the sleep time of the blank control group and the test drug group are recorded.

[0036] After administration of the test drug, the mice in each dose group had normal activities and did not fall asleep directly. The results are shown in Table 1. Subsequent evaluation of other effects can be carried out.

[0037] Table 1: Direct sleep test results

[0038] 1.2 Prolonged sodium pentobarbital sleep test 30 minutes after the last administration, each group of mice was intraperitoneally injected with 50 mg / kg sodium pentobarbital solution, with an injection volume of 10 mL / kg. The disappearance of the righting reflex for more than 60 seconds was taken as the sleep index, and the sleep time of the mice was recorded to observe whether the test drug could prolong the sodium pentobarbital sleep time. The results are shown in Table 2.

[0039] Table 2: Results of the test on prolonging the sleeping time of sodium pentobarbital (X±SD) (n=10)

[0040] Note: Compared with the blank control group, *P<0.05, **P<0.01; compared with Example 3, # P<0.05, ## P<0.01.

[0041] Compared with the blank control group, Examples 1-3 and Comparative Examples 1-6 can significantly prolong the sleep time of mice induced by sodium pentobarbital (P < 0.05 or P < 0.01); compared with Example 3, the effect of Examples 1-2 is equivalent to that of Example 3, the differences between Comparative Examples 5 and 6 and Example 3 are statistically significant (P < 0.05), and the difference between Comparative Examples 1-4 and Example 3 is significant (P < 0.01).

[0042] 1.3 Subthreshold dose hypnosis test of sodium pentobarbital 30 minutes after the last administration, each group of mice was intraperitoneally injected with 35 mg / kg sodium pentobarbital solution, with an injection volume of 10 mL / kg. The disappearance of the righting reflex for more than 60 seconds was taken as the sleep index. The number of mice falling asleep within 30 minutes was recorded and the sleep rate was calculated. The results are shown in Table 3.

[0043] Table 3: Results of subthreshold dose hypnosis test of sodium pentobarbital

[0044] Note: Compared with the blank control group, *P<0.05; compared with Example 3, # P<0.05.

[0045] Under the action of sodium pentobarbital (35 mg / kg), the number of mice falling asleep in each group was more than that in the blank control group. Compared with the blank control group, the number of mice falling asleep in Examples 1-3 and Comparative Examples 5-6 increased significantly (P < 0.05), indicating that the compositions of Examples 1-3 and Comparative Examples 5-6 had a synergistic hypnotic effect with the subthreshold dose of sodium pentobarbital; compared with Example 3, the effect of Example 1-2 was equivalent to that of Example 3, and the difference between Comparative Examples 1-6 and Example 3 was statistically significant (P < 0.05).

[0046] 1.4 Pentobarbital sleep latency test 30 minutes after the last administration, 300 mg / kg sodium pentobarbital solution was intraperitoneally injected into each group of mice, with an injection volume of 10 mL / kg. The disappearance of the righting reflex was used as the sleep index, and the sleep latency of each group of mice was recorded to observe the effect of the test drug on the sleep latency of sodium pentobarbital. The results are shown in Table 4.

[0047] Table 4: Results of sodium pentobarbital sleep latency test (X±SD) (n=10)

[0048] Note: Compared with the blank control group, *P<0.05, **P<0.01; compared with Example 3, # P<0.05.

[0049] The results show that the sleep latency of mice in each drug-treated group is shorter than that in the blank control group, and the difference is statistically significant or significantly different (P < 0.05 or P < 0.01); and the effect of Examples 1-3 is significantly better than that of each control group, and the difference is statistically significant (P < 0.05).

[0050] The body weight results of mice in each group on the 0th day and the 30th day of the experiment are shown in Table 5.

[0051] Table 5: Body weight of mice in each group on day 0 and day 30 of the experiment (X±SD) (n=10)

[0052] On the 0th and 30th days of the experiment, there was no difference in the body weight of mice among the groups.

[0053] According to the above experimental results on the effect on the sleep of mice, after the composition of the present invention was administered by gavage for 30 consecutive days, the mice did not experience direct sleep phenomenon, the sleep time of mice induced by sodium pentobarbital was significantly prolonged, the incidence of sleep in mice induced by sodium pentobarbital was significantly increased, and the sleep latency of mice was significantly shortened. The results suggest that the composition of the present invention has the function of improving sleep in animals, and the effect is better than that of each comparative example.

[0054] Finally, it should be noted that the above content is only used to illustrate the technical solution of the present invention, rather than to limit the scope of protection of the present invention. Simple modifications or equivalent substitutions of the technical solution of the present invention by ordinary technicians in this field do not deviate from the essence and scope of the technical solution of the present invention.

Claims

1. A brain peptide composition for relieving anxiety and improving sleep, comprising the following components by mass: 1-5 parts of apple concentrated powder, 0.1-0.6 parts of brain peptide powder, 1-5 parts of casein peptide, 0.5-1.5 parts of jujube kernel composite powder, 0.1-0.5 parts of γ-aminobutyric acid, 0.5-1.5 parts of lemon concentrated powder, 0.5-3 parts of stachyose and 0.05-0.3 parts of taurine.

2. The brain peptide-containing composition according to claim 1, characterized in that The brain peptide-containing composition comprises the following components by mass: 1-3 parts of apple concentrated powder, 0.1-0.3 parts of brain peptide powder, 1-3 parts of casein peptide, 0.5-1 parts of jujube seed composite powder, 0.1-0.3 parts of γ-aminobutyric acid, 0.5-1.2 parts of lemon concentrated powder, 0.5-2 parts of stachyose and 0.05-0.15 parts of taurine.

3. The brain peptide-containing composition according to claim 1, characterized in that The brain peptide-containing composition comprises the following components by mass: 3 parts of apple concentrated powder, 0.2 parts of brain peptide powder, 2 parts of casein peptide, 0.8 parts of jujube seed composite powder, 0.2 parts of gamma-aminobutyric acid, 1 part of lemon concentrated powder, 1 part of stachyose and 0.1 parts of taurine.

4. The brain peptide-containing composition according to claim 1, characterized in that The weight ratio of the Suanzaorensis seed composite powder to gamma-aminobutyric acid is 3-8:

1.

5. The brain peptide-containing composition according to claim 1, characterized in that: The weight ratio of the brain peptide powder, casein peptide and gamma-aminobutyric acid is 1-2:8-12:1-2.

6. The brain peptide-containing composition according to any one of claims 1 to 5, characterized in that: The brain peptide-containing composition further comprises pharmaceutically acceptable excipients.

7. The brain peptide-containing composition according to claim 6, characterized in that: The auxiliary material is selected from at least one of citric acid, xanthan gum, sucralose, maltodextrin, soluble starch and lactose.

8. A method for preparing a brain peptide-containing composition according to any one of claims 1 to 7, characterized in that: The steps include: Mix apple concentrated powder, brain peptide powder, casein peptide, jujube seed composite powder, gamma-aminobutyric acid, lemon concentrated powder, stachyose and taurine, and add auxiliary materials to obtain the product.

9. Use of the brain peptide composition according to any one of claims 1 to 7 or the brain peptide composition prepared by the preparation method according to claim 8 in preparing functional foods for relieving anxiety and improving sleep.

10. The use according to claim 9, characterized in that: The functional food is a solid beverage, a compressed candy or an oral liquid.

Citation Information

Patent Citations

  • Formula of polypeptide herbaceous solid beverage having function of improving sleep

    CN107594269A

  • Casein zymolyte with sleep aiding function, casein zymolyte composition and preparation method of casein zymolyte composition

    CN113424968A

  • Casein peptide with sleep improving effect as well as preparation method and application of casein peptide

    CN115304664A

  • Compound for improving sleep and application thereof

    CN118383525A

  • Composition for improving sleep quality and preparation method and application thereof

    CN118787096A

Cited By

  • Brain peptide hydrolysate-containing beverage composition for improving brain function as well as preparation method and application of brain peptide hydrolysate-containing beverage composition

    CN120226725A

  • Brain function enhancing peptide hydrolysate-containing beverage composition and preparation method and application thereof

    CN120226725B

  • Brain peptide-containing sustained-release granules, preparation method thereof, brain function improving drink and application

    CN120240647A

  • Radix ophiopogonis and pericarpium citri reticulatae composition for relieving anxiety mood and improving sleep as well as preparation method and application of radix ophiopogonis and pericarpium citri reticulatae composition

    CN120884649A

  • Active peptide composition for adjusting emotion and improving side effects of medicine

    CN121102435A